BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 26
• 27
• 28
• 31

• Genetown

  Novelos Therapeutics, Inc. CEO Buys 150,000 Shares of NVLT

  December 20, 2007

   · 

  1 min read
• Genetown

  Biopure Corporation Receives Notice of NASDAQ Listing Requirements

  December 20, 2007

   · 

  2 min read
• Business

  Bio-Reference Laboratories Announces Record-Breaking Year-End and Fourth Quarter Results

  December 20, 2007

   · 

  1 min read
• Drug Development

  InSite Vision Initiates Pivotal Phase 3 Trials for AzaSite Plus(TM)

  December 20, 2007

   · 

  1 min read
• Deals

  Valeant Pharmaceuticals International Sells Hep-C Drug Infergen(R) to Three Rivers Pharmaceuticals, LLC for $91 Million

  December 20, 2007

   · 

  5 min read
• Drug Development

  Human Genome Sciences, Inc. Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy

  December 20, 2007

   · 

  9 min read
• Business

  Nektar Therapeutics Extends Hemophilia Drug Deal with Baxter International, Inc.; Nektar will Receive up to $44 Million

  December 20, 2007

   · 

  4 min read
• Policy

  Indevus Pharmaceuticals, Inc. Gets Non-Approvable Letter for Cancer Therapy

  December 20, 2007

   · 

  5 min read
• Biotech Beach

  Ardea Biosciences, Inc. Announces $40 Million Private Placement

  December 20, 2007

   · 

  3 min read
• Business

  Neoprobe Corporation Announces Extension of Marketing Agreement with Ethicon Endo-Surgery, Inc.

  December 20, 2007

   · 

  1 min read